The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.
Open accessAbstract
A nontoxic mutant (LTK7) of the Escherichia coli heat-labile enterotoxin (LT) lacking ADP-ribosylating activity but retaining holotoxin formation was constructed. By using site-directed mutagenesis, the arginine at position 7 of the A subunit was replaced with lysine. This molecule, which was nontoxic in several assays, was able to bind to eukaryotic cells and acted as a mucosal adjuvant for co-administered proteins; BALB/c mice immunized intranasally with LTK7 and ovalbumin developed high levels of serum and local antibodies to ovalbumin and toxin. In addition, mice immunized intranasally with fragment C of tetanus toxin and LTK7 were protected against lethal challenge with tetanus toxin. Thus nontoxic mutants of heat-labile toxin can act as effective intranasal mucosal adjuvants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mucosal immune system: from fundamental concepts to vaccine development
McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M., & Kiyono, H. (1992) · Vaccine · doi:10.1016/0264-410x(92)90021-b · Cited by 903
Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin
Spangler, B. D. (1992) · Microbiological Reviews · doi:10.1128/mmbr.56.4.622-647.1992 · Cited by 879
Handbook of Mucosal Immunology
(1994) · Elsevier eBooks · doi:10.1016/c2009-1-03796-4 · Cited by 706
Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
Elson, C. O., & Ealding, W. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.6.2736 · Cited by 444
Clare, J. J., Rayment, F. B., Ballantine, S. P., Sreekrishna, K. T., & Romanos, M. (1991) · Nature Biotechnology · doi:10.1038/nbt0591-455 · Cited by 393
Donta, S. T., Moon, H. W., & Whipp, S. C. (1974) · Science · doi:10.1126/science.183.4122.334 · Cited by 392
Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systems
Holmgren, J., Lycke, N., & Czerkinsky, C. (1993) · Vaccine · doi:10.1016/0264-410x(93)90039-z · Cited by 325
Clements, J. D., Hartzog, N. M., & Lyon, F. L. (1988) · Vaccine · doi:10.1016/0264-410x(88)90223-x · Cited by 284
Lycke, N., Tsuji, T., & Holmgren, J. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220915 · Cited by 283
Czerkinsky, C., Russell, M. W., Lycke, N., Lindblad, M., & Holmgren, J. (1989) · Infection and Immunity · doi:10.1128/iai.57.4.1072-1077.1989 · Cited by 251
Cited by
Diarrheagenic Escherichia coli
Nataro, J. P., & Kaper, J. B. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.142 · Cited by 5,006
Vaccine adjuvants: Current state and future trends
Petrovsky, N., & Aguilar, J. C. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01272.x · Cited by 1,005
NALT- versus PEYER'S-patch-mediated mucosal immunity
Kiyono, H., & Fukuyama, S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1439 · Cited by 745
Adjuvants—a classification and review of their modes of action
Cox, J. C., & Coulter, A. R. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00183-1 · Cited by 682
Development of a Mouse Model of Helicobacter pylori Infection that Mimics Human Disease
Marchetti, M., Aricò, B., Burroni, D., Figura, N., Rappuoli, R., & Ghiara, P. (1995) · Science · doi:10.1126/science.7886456 · Cited by 562
Self-citationSingh, M., & O'Hagan, D. (1999) · Nature Biotechnology · doi:10.1038/15058 · Cited by 506
GIUDICE, E., & CAMPBELL, J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.12.003 · Cited by 496
INTERACTION OF ANTIGENS AND ANTIBODIES AT MUCOSAL SURFACES
Lamm, M. E. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.micro.51.1.311 · Cited by 429
Recent developments in adjuvants for vaccines against infectious diseases
O'Hagan, D. T., MacKichan, M. L., & Singh, M. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00101-0 · Cited by 332
Michetti, P., Kreiss, C., Kotloff, K. L., Porta, N., Blanco, J., Bachmann, D., Herranz, M., Saldinger, P. F., Corthésy–Theulaz, I., Losonsky, G., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70063-6 · Cited by 310
A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity
Yamamoto, S., Kiyono, H., Yamamoto, M., Imaoka, K., Yamamoto, M., Fujihashi, K., Van Ginkel, F. W., Noda, M., Takeda, Y., & McGhee, J. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5267 · Cited by 304
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
Pizza, M., Giuliani, M. M., Fontana, M. R., Monaci, E., Douce, G., Dougan, G., Mills, K. H. G., Rappuoli, R., & Del Giudice, G. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00553-3 · Cited by 304
Self-citationAdjuvants: Classification,Modus Operandi, and Licensing
Apostólico, J. D. S., Lunardelli, V. A. S., Coirada, F. C., Boscardin, S. B., & Rosa, D. S. (2016) · Journal of Immunology Research · doi:10.1155/2016/1459394 · Cited by 287
Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
Rappuoli, R., Pizza, M., Douce, G., & Dougan, G. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01523-6 · Cited by 284
Self-citationGiuliani, M. M., Del Giudice, G., Giannelli, V., Dougan, G., Douce, G., Rappuoli, R., & Pizza, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1123 · Cited by 258
Self-citationNorton, E. B., Lawson, L. B., Freytag, L. C., & Clements, J. D. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00538-10 · Cited by 221
Microparticles as vaccine adjuvants and delivery systems
O’Hagan, D. T., & Singh, M. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.269 · Cited by 214
Metadata
- Authors
- Douce, G., Turcotte, C., Cropley, I., Roberts, M., Pizza, M., Domenghini, M., Rappuoli, R., & Dougan, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-02-28
- Volume
- 92
- Issue
- 5
- Pages
- 1644-1648
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2012188057
- Cited by
- 278
- References
- 14
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.